Skip to content

Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

Use of CGM in Adolescents With Poorly-controlled Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01586065
Enrollment
10
Registered
2012-04-26
Start date
2012-02-29
Completion date
2014-06-30
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

type 1 diabetes, adolescents, poor control, CGM

Brief summary

The purpose of this study is to see if children and adolescents with poorly controlled type 1 diabetes will benefit from using a continuous glucose monitor (CGM), a device that can be used to check blood sugars.

Detailed description

Adolescents with type 1 diabetes, HbA1c ≥9% on insulin pumps were admitted to the clinical research center and a continuous glucose sensor was inserted. Sensor glucose (SG) values were compared to plasma glucose measured at least hourly using Yellow Springs Instrument's (YSI) glucose analyzer. SG rather than YSI was used for treatment decisions unless YSI was \<70 mg/dL or specific criteria indicating SG and YSI were very discordant were met.

Interventions

DEVICEContinuous Glucose Monitor (CGM)

CGM during 24-hr CRC stay.

Sponsors

Nemours Children's Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 12 to \<18 years old * T1D for at least one year * Treatment with insulin pump therapy * A1c ≥9% * Willingness to comply with study procedures

Exclusion criteria

* Current diabetic ketoacidosis * Hypoglycemia unawareness * Chronic use of medications that affect recognition of hypoglycemia (e.g., beta blockers) * Chronic use of medications that mimic symptoms of high or low blood sugars (e.g., decongestants) * Recent or frequent severe hypoglycemia (2 episodes in the last year; 1 episode in the last 6 months) * Skin rashes or conditions that may affect CGM placement and wear

Design outcomes

Primary

MeasureTime frameDescription
Number of High Glucose Correction Doses Administered.24 hrsPrincipal study outcome was comparing insulin doses using pre- and post-meal sensor versus plasma glucose values. All insulin dose calculations over a 24-hour period were made using sensor glucose concentrations; these doses were compared to the those calculated as if plasma glucose were to be used instead for dose calculations.

Secondary

MeasureTime frameDescription
Pre- and Post-meal (2-3 Hour) Glucose Levels24 hoursMean sensor and plasma pre- and post-meal glucose concentrations for all dinner (n=8), bedtime snack (n=8), and breakfast (n=10) during the study period.

Countries

United States

Participant flow

Recruitment details

Type 1 diabetes, HbA1c ≥9% on insulin pumps

Participants by arm

ArmCount
CGM Use in Adolescents With Poorly Controlled T1D
Adolescents with poorly controlled T1D were admitted to CRC and CGM was placed. The safety of using real-time sensor glucose (SG) data for treatment decisions in adolescents with poorly controlled type 1 diabetes was assessed.
10
Total10

Baseline characteristics

CharacteristicCGM Use in Adolescents With Poorly Controlled T1D
Age, Categorical
<=18 years
10 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous16.3 years
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
2 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Number of High Glucose Correction Doses Administered.

Principal study outcome was comparing insulin doses using pre- and post-meal sensor versus plasma glucose values. All insulin dose calculations over a 24-hour period were made using sensor glucose concentrations; these doses were compared to the those calculated as if plasma glucose were to be used instead for dose calculations.

Time frame: 24 hrs

Population: Ten adolescents with poorly controlled type 1 diabetes on insulin pumps were admitted to the clinical research center and a continuous glucose sensor was inserted. Insulin dose calculations based on sensor glucose were compared to calculations made as if based on plasma glucose. 23 paired sensor/plasma glucose values for corrections were analyzed.

ArmMeasureGroupValue (COUNT_OF_UNITS)
Insulin Correction Doses Determined Using Sensor Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +1 unit3 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using Sensor Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = 0 units7 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using Sensor Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -2 units0 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using Sensor Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -1 unit5 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using Sensor Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +2 units0 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using YSI Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = 0 units1 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using YSI Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -2 units2 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using YSI Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -1 unit5 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using YSI Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +1 unit0 sensor/plasma glucose-based insulin dose
Insulin Correction Doses Determined Using YSI Glucose ReadingsNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +2 units0 sensor/plasma glucose-based insulin dose
All Correction Doses AdministeredNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +2 units0 sensor/plasma glucose-based insulin dose
All Correction Doses AdministeredNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = +1 unit3 sensor/plasma glucose-based insulin dose
All Correction Doses AdministeredNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -2 units2 sensor/plasma glucose-based insulin dose
All Correction Doses AdministeredNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = 0 units8 sensor/plasma glucose-based insulin dose
All Correction Doses AdministeredNumber of High Glucose Correction Doses Administered.Difference between SG and YSI dose calculated (SG-YSI dose) = -1 unit10 sensor/plasma glucose-based insulin dose
Secondary

Pre- and Post-meal (2-3 Hour) Glucose Levels

Mean sensor and plasma pre- and post-meal glucose concentrations for all dinner (n=8), bedtime snack (n=8), and breakfast (n=10) during the study period.

Time frame: 24 hours

ArmMeasureGroupValue (MEAN)Dispersion
Insulin Correction Doses Determined Using Sensor Glucose ReadingsPre- and Post-meal (2-3 Hour) Glucose LevelsPre-meal glucose, mean (SD)157 mg/dLStandard Deviation 9
Insulin Correction Doses Determined Using Sensor Glucose ReadingsPre- and Post-meal (2-3 Hour) Glucose LevelsPost-meal glucose, mean (SD)174 mg/dLStandard Deviation 10
Insulin Correction Doses Determined Using YSI Glucose ReadingsPre- and Post-meal (2-3 Hour) Glucose LevelsPre-meal glucose, mean (SD)163 mg/dLStandard Deviation 11
Insulin Correction Doses Determined Using YSI Glucose ReadingsPre- and Post-meal (2-3 Hour) Glucose LevelsPost-meal glucose, mean (SD)183 mg/dLStandard Deviation 12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026